Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
|
HARROW HEALTH, INC. (IMMY)
|
Add to portfolio |
|
|
|
| Price: |
$6.78
| | Metrics |
| OS: |
35.1
|
M
| |
-74
|
% ROE
|
| Market cap: |
$238
|
M
| |
5
|
% ROIC
|
|
Net debt:
|
$156
|
M
| |
39.7
|
x Debt/EBITDA
|
|
EV:
|
$394
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$3.9
|
M
| |
100.4
|
x EV/EBITDA
|
|
EBIT
|
($3.2)
|
M
| |
|
|
| EPS |
($0.56)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 88.6 | 72.5 | 48.9 | 51.2 | 41.4 | 26.8 | 19.9 | 9.7 |
| Revenue growth | 22.2% | 48.3% | -4.5% | 23.7% | 54.5% | 34.3% | 105.2% | 485.3% |
| Cost of goods sold | 25.4 | 18.2 | 14.5 | 16.7 | 16.5 | 13.5 | 9.8 | 5.2 |
| Gross profit | 63.2 | 54.3 | 34.4 | 34.4 | 24.9 | 13.3 | 10.1 | 4.5 |
| Gross margin | 71.3% | 74.9% | 70.4% | 67.3% | 60.1% | 49.6% | 50.7% | 46.4% |
| Selling, general and administrative | 58.2 | 41.3 | 31.2 | 33.1 | 29.2 | 25.0 | | |
| Sales and marketing | | | | | | | 7.4 | 6.5 |
| Research and development | 3.1 | 11.1 | 2.4 | 2.1 | 0.8 | 0.4 | 0.7 | 0.3 |
| General and administrative | | | | | | | 17.6 | 12.5 |
| EBITA | -7.0 | -3.3 | 5.7 | -0.6 | -5.4 | -11.8 | -15.2 | -14.5 |
| EBITA margin | -7.8% | -4.6% | 11.6% | -1.1% | -13.0% | -44.1% | -76.4% | -148.9% |
| Amortization of intangibles | 1.6 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.4 | 0.4 |
| EBIT | -8.5 | -3.5 | 5.5 | -0.8 | -5.6 | -12.2 | -15.6 | -14.8 |
| EBIT margin | -9.6% | -4.8% | 11.2% | -1.5% | -13.6% | -45.4% | -78.1% | -152.6% |
| Pre-tax income | -14.0 | -17.9 | -3.4 | -0.1 | 14.6 | -12.9 | -19.2 | -15.9 |
| Income taxes | 0.1 | 0.1 | 0.0 | -0.3 | 0.0 | -0.9 | -0.1 | 0.0 |
| Tax rate | | | | 234.4% | 0.0% | 7.2% | 0.6% | 0.0% |
| Net income | -14.1 | -18.5 | -3.4 | 0.2 | 14.6 | -12.0 | -19.1 | -15.9 |
| Net margin | -15.9% | -25.5% | -6.9% | 0.3% | 35.3% | -44.8% | -95.7% | -163.6% |
| |
| Diluted EPS | ($0.51) | ($0.69) | ($0.13) | $0.01 | $0.61 | ($0.60) | ($1.50) | ($1.66) |
| Shares outstanding (diluted) | 27.5 | 26.8 | 25.9 | 26.5 | 23.8 | 20.0 | 12.7 | 9.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|